VCG
MD icon

Vantage Consulting Group’s Pediatrix Medical MD Stock Holding History

Vantage Consulting Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,736
Closed -$43K – 954
2020
Q4 		$43K Buy
+1,736
New +$32.6K ﹤0.01% 503

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Vantage Consulting Group's MD Position: Q1 2021 in Review

Vantage Consulting Group sold out of Pediatrix Medical (MD) in Q1 2021, closing a stake of 1,736 shares — an estimated $43K sold.

Vantage Consulting Group first reported a position in MD in Q4 2020 and held it in 1 quarter. The position peaked at $43K in Q4 2020. 207 funds tracked by Wall St. Rank hold MD as of Q1 2021.

  • Vantage Consulting Group reported no remaining Pediatrix Medical position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 1,736 Pediatrix Medical shares in Q1 2021, an estimated $43K.
  • Vantage Consulting Group first reported a position in Pediatrix Medical in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Pediatrix Medical position peaked at $43K in Q4 2020.
  • 207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.